HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Role of differentiation of liver sinusoidal endothelial cells in progression and regression of hepatic fibrosis in rats.

AbstractBACKGROUND & AIMS:
Capillarization, characterized by loss of differentiation of liver sinusoidal endothelial cells (LSECs), precedes the onset of hepatic fibrosis. We investigated whether restoration of LSEC differentiation would normalize crosstalk with activated hepatic stellate cells (HSC) and thereby promote quiescence of HSC and regression of fibrosis.
METHODS:
Rat LSECs were cultured with inhibitors and/or agonists and examined by scanning electron microscopy for fenestrae in sieve plates. Cirrhosis was induced in rats using thioacetamide, followed by administration of BAY 60-2770, an activator of soluble guanylate cyclase (sGC). Fibrosis was assessed by Sirius red staining; expression of α-smooth muscle actin was measured by immunoblot analysis.
RESULTS:
Maintenance of LSEC differentiation requires vascular endothelial growth factor-A stimulation of nitric oxide-dependent signaling (via sGC and cyclic guanosine monophosphate) and nitric oxide-independent signaling. In rats with thioacetamide-induced cirrhosis, BAY 60-2770 accelerated the complete reversal of capillarization (restored differentiation of LSECs) without directly affecting activation of HSCs or fibrosis. Restoration of differentiation to LSECs led to quiescence of HSCs and regression of fibrosis in the absence of further exposure to BAY 60-2770. Activation of sGC with BAY 60-2770 prevented progression of cirrhosis, despite continued administration of thioacetamide.
CONCLUSIONS:
The state of LSEC differentiation plays a pivotal role in HSC activation and the fibrotic process.
AuthorsGuanhua Xie, Xiangdong Wang, Lei Wang, Lin Wang, Roscoe D Atkinson, Gary C Kanel, William A Gaarde, Laurie D Deleve
JournalGastroenterology (Gastroenterology) Vol. 142 Issue 4 Pg. 918-927.e6 (Apr 2012) ISSN: 1528-0012 [Electronic] United States
PMID22178212 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
CopyrightCopyright © 2012 AGA Institute. Published by Elsevier Inc. All rights reserved.
Chemical References
  • 4-(((4-carboxybutyl) (2- (5-fluoro-2-((4'-(trifluoromethyl) biphenyl-4-yl)methoxy)phenyl)ethyl) amino)methyl)benzoic acid
  • Actins
  • Benzoates
  • Biphenyl Compounds
  • Enzyme Activators
  • Hydrocarbons, Fluorinated
  • Receptors, Cytoplasmic and Nuclear
  • Vascular Endothelial Growth Factor A
  • smooth muscle actin, rat
  • vascular endothelial growth factor A, rat
  • Thioacetamide
  • Nitric Oxide
  • Guanylate Cyclase
  • Soluble Guanylyl Cyclase
  • Cyclic GMP
Topics
  • Actins (metabolism)
  • Animals
  • Benzoates (pharmacology)
  • Biphenyl Compounds
  • Blotting, Western
  • Capillaries (drug effects, metabolism, pathology)
  • Cell Differentiation (drug effects)
  • Cell Proliferation
  • Cells, Cultured
  • Cyclic GMP (metabolism)
  • Disease Progression
  • Endothelial Cells (drug effects, metabolism, pathology)
  • Enzyme Activation
  • Enzyme Activators (pharmacology)
  • Guanylate Cyclase (metabolism)
  • Hepatic Stellate Cells (drug effects, metabolism, pathology)
  • Hydrocarbons, Fluorinated (pharmacology)
  • Liver (blood supply, drug effects, metabolism, pathology)
  • Liver Cirrhosis, Experimental (chemically induced, metabolism, pathology, prevention & control)
  • Male
  • Microscopy, Electron, Scanning
  • Nitric Oxide
  • Paracrine Communication (drug effects)
  • Phenotype
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Cytoplasmic and Nuclear (metabolism)
  • Signal Transduction
  • Soluble Guanylyl Cyclase
  • Thioacetamide
  • Vascular Endothelial Growth Factor A (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: